Astra must pay $215 Million - Alabama Jury Rules Drugmaker Overcharged Medicaid System, Appeal Planned

AstraZeneca PLC must pay Alabama $215 million after a state court ruled the company inflated prices for drugs it sold to the state's Medicaid system.

AstraZeneca to File Appeal Against Alabama Court's Verdict on Medicaid Drug Price Lawsuit

UK-based pharmaceutical company AstraZeneca Plc (AZN) on Friday confirmed that it intends to appeal yesterday's verdict by a state court jury in Alabama, which awarded the state $215 million in damages after finding that the company overcharged the Alabama State Medicaid Agency on its Medicaid drug price.

AstraZeneca Unit Must Pay $215 Million in Pricing Suit

A state court jury awarded Alabama $215 million in its Medicaid drug-price fraud suit against an AstraZeneca PLC unit.

Jury Orders AstraZeneca to Pay Damages in Suit

A state-court jury awarded Alabama $215 million in its Medicaid drug-price-fraud suit against an AstraZeneca PLC unit.

Alabama Jury Tells AstraZeneca to pay $215 mln, Update

AstraZeneca Plc said on Thursday it would appeal a jury ruling that it pay $215 million in damages, in an Alabama lawsuit related to drug pricing under the Medicaid health program for the needy.

Jury in Medicaid pharmaceutical fraud trial finds in favor of Alabama

MONTGOMERY - The jury in the Medicaid pharmaceutical fraud trial in Montgomery just moments ago found in favor of Alabama and recommended compensatory damages of $40 million and punitive damages of $175 million.

Alabama Wins $215M Verdict From AstraZeneca

A state court jury awarded Alabama $215 million Thursday in its Medicaid drug price fraud suit against drugmaker AstraZeneca Pharmaceuticals LP. The circuit court jury said the subsidiary of Britain's AstraZeneca PLC must pay $40 million in compensatory damages and $175 million in punitive damages.

Jury orders British drug firm to pay Alabama $215 million

MONTGOMERY, Ala. (AP) — A state court jury has awarded Alabama $215 million in its Medicaid drug price fraud suit against a British pharmaceutical firm.

Jury rules in state's favor in Medicaid drug fraud trial

MONTGOMERY — The jury in the Medicaid pharmaceutical fraud trial in Montgomery just moments ago found in favor of Alabama and recommended compensatory damages of $40 million and punitive damages of $175 million. The verdict was against AstraZeneca Corp., a drug manufacturer the state sued along with about 75 other drug manufacturers, alleging they overcharged Alabama’s Medicaid program for prescription drugs.

Jury out in Medicaid fraud trial

The jury is out in the Medicaid pharmaceutical fraud trial in Montgomery, with the attorney for the state asking for $39 million in compensatory damages and between $140 million and $250 million in punitive damages.